E 3040.
D000818:Animals; D052160:Benzothiazoles; D003093:Colitis, Ulcerative / Q000188:drug therapy; D015507:Drugs, Investigational / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D016859:Lipoxygenase Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011725:Pyridines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D013844:Thiazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors
D052160:Benzothiazoles; D015507:Drugs, Investigational; D005765:Gastrointestinal Agents; D016859:Lipoxygenase Inhibitors; D011725:Pyridines; D013844:Thiazoles; C095803:E 3040; D013930:Thromboxane-A Synthase